203 related articles for article (PubMed ID: 36698326)
1. HBx-induced PLA
Feng M; Yu Y; Chen Y; Yang X; Li B; Jiang W
Ren Fail; 2023 Dec; 45(1):2170808. PubMed ID: 36698326
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of podocyte pyroptosis aggravated by up-regulation of phospholipase A
Feng MX; An Q; Yu YN; Chen YQ; Yang XQ; Li BS; Jiang W
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1714-1723. PubMed ID: 37302862
[No Abstract] [Full Text] [Related]
3. [Hepatitis B virus X protein promotes podocyte pyroptosis in hepatitis B virus-associated glomerulonephritis by down-regulating microRNA -223 targeting NLRP3 inflammasome].
Yu YN; Chen YQ; Li BS; Yang XQ; Feng MX; Jiang W
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 39(1):20-31. PubMed ID: 36776011
[No Abstract] [Full Text] [Related]
4. Hepatitis B virus X mediates podocyte pyroptosis by regulating the ROS/NLRP3 signaling pathway in hepatitis B virus-associated glomerulonephritis.
Yu Y; Dong H; Sun J; Li B; Chen Y; Feng M; Yang X; Jiang W
Iran J Basic Med Sci; 2022 Jan; 25(1):103-109. PubMed ID: 35656447
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-223 downregulation promotes HBx-induced podocyte pyroptosis by targeting the NLRP3 inflammasome.
Yu Y; Dong H; Zhang Y; Sun J; Li B; Chen Y; Feng M; Yang X; Gao S; Jiang W
Arch Virol; 2022 Sep; 167(9):1841-1854. PubMed ID: 35731327
[TBL] [Abstract][Full Text] [Related]
6. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
Gao Y; Ma Y; Xie D; Jiang H
Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation.
Xie WH; Ding J; Xie XX; Yang XH; Wu XF; Chen ZX; Guo QL; Gao WY; Wang XZ; Li D
Inflamm Res; 2020 Jul; 69(7):683-696. PubMed ID: 32347316
[TBL] [Abstract][Full Text] [Related]
8. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.
Conley SM; Abais-Battad JM; Yuan X; Zhang Q; Boini KM; Li PL
Free Radic Biol Med; 2017 May; 106():236-244. PubMed ID: 28193546
[TBL] [Abstract][Full Text] [Related]
9. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
[TBL] [Abstract][Full Text] [Related]
11. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
Lv C; Cheng T; Zhang B; Sun K; Lu K
Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
[No Abstract] [Full Text] [Related]
12. GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.
Li X; Jiang X; Jiang M; Wang ZF; Zhao T; Cao SM; Li QM
Acta Diabetol; 2024 Feb; 61(2):225-234. PubMed ID: 37847379
[TBL] [Abstract][Full Text] [Related]
13. sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor.
Pan Y; Wan J; Liu Y; Yang Q; Liang W; Singhal PC; Saleem MA; Ding G
Sci Rep; 2014 Oct; 4():6660. PubMed ID: 25335547
[TBL] [Abstract][Full Text] [Related]
14. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17A participates in podocyte injury by inducing IL-1β secretion through ROS-NLRP3 inflammasome-caspase-1 pathway.
Yan J; Li Y; Yang H; Zhang L; Yang B; Wang M; Li Q
Scand J Immunol; 2018 Apr; 87(4):e12645. PubMed ID: 29446486
[TBL] [Abstract][Full Text] [Related]
16. sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1
Yang L; Wu Y; Lin S; Dai B; Chen H; Tao X; Li G; Wan J; Pan Y
FASEB J; 2021 Feb; 35(2):e21170. PubMed ID: 33184968
[TBL] [Abstract][Full Text] [Related]
17. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
Zhang Q; Conley SM; Li G; Yuan X; Li PL
Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
19. Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway.
Yu Q; Zhang M; Qian L; Wen D; Wu G
Life Sci; 2019 May; 225():1-7. PubMed ID: 30935950
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.
Bai M; Chen Y; Zhao M; Zhang Y; He JC; Huang S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F556-F564. PubMed ID: 28052869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
